Expanded labeling for sacubitril/valsartan (Entresto, Novartis) to encompass adults with power coronary heart failure (HF) with left ventricular ejection fraction (LVEF) decrease than commonplace could…
Expanded labeling for sacubitril/valsartan (Entresto, Novartis) to encompass adults with power coronary heart failure (HF) with left ventricular ejection fraction (LVEF) decrease than commonplace could…